Орексигенные пептиды как факторы синхронизации циркадианного осциллятора

Автор: Петрова Альбина Анатольевна, Рязанцева Татьяна Викторовна, Инюшкин Алексей Николаевич

Журнал: Вестник медицинского института "РЕАВИЗ": реабилитация, врач и здоровье @vestnik-reaviz

Статья в выпуске: 2 (22), 2016 года.

Бесплатный доступ

В статье рассмотрена физиологическая роль орексигенных пептидов, нейропептида Y и грелина как факторов синхронизации циркадианного осциллятора супрахиазматического ядра млекопитающих.

Циркадианные ритмы, супрахиазматическое ядро, орексигенные пептиды, нейропептид y, грелин

Короткий адрес: https://sciup.org/14344189

IDR: 14344189

Список литературы Орексигенные пептиды как факторы синхронизации циркадианного осциллятора

Ашофф, Ю. Биологические ритмы. -М.: Мир, 1984. -Т. 1. -414 с.
Романцова Т.И. Лептин и грелин: антагонизм и взаимодействие в регуляции энергетического обмена/Г.Е. Волкова//Ожирение и метаболизм. -2005. -№ 2. -C. 2-9.
Acuna-Goycolea, C. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus/A.N van den Pol., K Obata, N. Tamamaki., Y. Yanagawa Y.,.//J. Neurosci. -2005. -№ 25. -P. 7406-7419.
Albers H.E. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms/C.F. Ferris//Neurosci Lett. -1984. -№ 50. -P. 163-168.
Alman J. Weidht in the balance//Neuroendocrynology. -2002. -№ 76. -P. 131-136.
Ariyasu H. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-line activing levels in humans/K. Takaya., T. Tagami//J Clin Endocrinol Metab. -2001. -P. 86.
Belle, M.D.C. Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock/A.T.L. Hughes., D Burdakov., D.A. Bechtold., H.D,Piggins., M. Pierucci., P Cunningham//J. Neurosci. -2014. -№ 34. -P. 3607-3621.
Benoit, S.C. Novel functions of orexigenic hypothalamic peptides: From genes to behavior/A.L. Tracy, D. Choi, J.F. Davis//Nutrition. -2008. -№ 24. -P. 843-847.
Biello, S.M. Neuropeptide Y and behaviorally induced phase shifts/D. Janik., N. Mrosovsky//Neuroscience. -1994. -№ 1. -P. 273-279.
Biello, S.M. Neuropeptide Y and glutamate block each other’s phase shifts in the suprachiasmatic nucleus in vitro/D. Golombek., M.E. Harrington//Neuroscience. -1997. -№ 77. -P. 1049-1057.
Blum, I.D. Reduced anticipatory locomotor responses to scheduled meals in ghrelin receptor deficient mice/A. Abizaid., E.W. Lamont., M.W. Sleeman., R. Khazall., T.L. Horvath., Z. Patterson//Neuroscience. -2009. -№ 164. -P. 351-359.
Botchkina, G.I. Organization of permanent and transient neuropeptide Y-immunoreactive neuron groups and fiber systems in the developing hamster diencephalon/L.P. Morin//J Comp Neurol. -1995. -№ 357. -P. 573-602.
Brothers, S.P. Therapeutic potential of neuropeptide Y (NPY) receptor ligands/C. Wahlestedt//EMBO Mol.Med. -2010. -№ 2. -P. 429-39.
Card, J.P. Organization of lateral geniculate-hypo-thalamic connections in the rat/R.Y. Moore//J. Comp. Neurol. -1989. -№ 284. -P. 135-147.
Dallman, M.F. Filling the interstices: ghrelin Neurons plug several holes in regulation of energy balance//Neuron. -2003. -№ 37. -P. 550 -553.
Fuxe, K. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat/A. Harfstrand., L.F.Agnati//Acta Physiol Scand. -1983. -№ 118. -P. 189-192.
Ghigo, E. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor/F. Broglio., E. Arvat., M. Maccario., M. Papotti., G. Muccioli//Clinical Endocrinology. -2005. -№ 62. -P. 1-17.
Gualillo, O. Ghrelin, a novel placental derived hormone/J.E.Caminos., M. Blanco//Endocrinology. -2001. -№ 142. -P. 788-794.
Hansen, M.J. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat/M.J. Morris., V. Jovanovska//J Neurochem. -2004. -№ 88. -P. 909-916.
Hastings, M. Circadian clocks: regulators of endocrine and metabolic rhythms/E.S. Maywood., J.S. O’Neil//J. Endocrinol. -2007. -№ 195. -P. 187-198.
Hosoda, H. Ghrelin and the regulation of food intake and energy balance/K. Kangawa., Kojima M.//Mol interventions. -2002. -№ 2. -P. 494-503.
Huhman, K.L. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters/H.E. Albers., T.O. Babagbemi//Brain Res. -1995. -№ 675. -P. 333-336.
Huhman, K.L. Tetrodotoxin blocks NPY-induced but not muscimol-induced phase advances of wheel-running activity in Syrian hamsters/C.F. Gillespie., C.L. Marvel., E.M. Mintz., H.E Albers//Brain Res. -1997. -№ 772. -P. 176-180.
Huhman, K.L., Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness/H.E. Albers//Peptides. -1994. -№ 15. -P. 1475-1478.
Inyushkin, A.N. Melatonin modulates spike coding in the rat suprachiasmatic nucleus/J. A.Gonzalez., G.S. Bhumbra., R. E. J. Dyball//J. Neuroendocrinol. -2007. -№ 19. -P. 671-681.
Klisch, C. Orexin а modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro/A.N. Inyushkin, J. Mordel, D. Karnas, P. Pevet, H. Meissl//Eur. J. Neurosci. -2009. -№ 30. -Р. 65-75.
Kojima, M. Ghrelin is a growth-hormone-releseing acylated peptide from.tomach/H. Nosoda, Y. Date//Nature. 1999. № 402. р.656-660.
Lall, G.S. A ttenuation of phase shifts to light by activity or neuropeptide Y a time course study/M. Biello//Brain Research. 2002. № 957. Р. 109-116.
Lall, G.S. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli/M. Biello//Neuroscience. 2003. № 120. Р. 915-921.
Lamont, E.W. Ghrelin receptor-knockout mice display alterations in circadian rhythms of activity and feeding under constant lighting conditions/A. Abizaid., J. Bruton., I. D. Blum//European Journal of Neuroscience. 2014. № 39. P. 207-217.
Lamont, E.W. Ghrelin receptor-knockout mice display alterations in circadian rhythms of activity and feeding under constant lighting conditions/J. Bruton, I.D. Blum, A. Abizaid//Eur. J. Neurosci. 2014. № 39. Р. 207-217.
Lamont, E.W. Ghrelin-deficient mice have fewer orexin cells and reduced cFOS expression in the mesolimbic dopamine pathway under a restricted feeding paradigm/Z. Patterson, T. Rodrigues, O. Vallejos, I.D. Blum A. Abizaid//Neuroscience. 2012. № 218. Р. 12-19.
Larhammar, D. Molecular evolution of NPY receptor subtypes/E. Salaneck//Neuropeptides. 2004. № 38. Р.141-151.
LeSauter, J. Stomach ghrelin-secreting cells as food-entrainable circadian clocks/N. Hoque, M. Weintraub, D.W. Pfaff, R. Silver//Proc. Natl. Acad. Sci. USA. 2009. № 106. Р.13582-13587.
Lundberg, J.M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man/L. Terenius, T. Hokfelt, M. Goldstein//Neurosci Lett. 1983. № 42. Р. 167-172.
Mc Dermott, B.J. NPY and cardiac diseases/D. Bell//Curr Top Med Chem. 2007. № 7. Р. 1692-1703.
Mitchell, V. Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary/S. Bouret, J.C. Beauvillain, A. Schilling, M. Perret, C. Kordon, J. Epelbaum//Comp. Neurol. 2001. № 429. Р. 69-489.
Nagaya, N. Hemodinamic and hormonal effects of human ghrelin in healthy volunteers/M. Kojima, M. Uematsu//Phisiol Regul. 2002. Р. 280.
Norvath, T.L. Minireview: Ghrelin and the regulation of sex hormones on circulating total and active ghrelin in health/S. Diano, P. Sotonny//Abstracts of 11th Meeting of the European Neuroendocrine Association. 2004. P. 82.
Raposinho, P. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism/D.D. Pierroz, P. Broqua, R.B. White, T. Pedrazzini, M.L. Aubert//Mol Cell Endocrinol. 2001. № 185. Р. 195-204.
Redrobe, J.P. Neuropeptide Y (NPY) and depression: from animal studies to the human condition./Y. Dumont, R. Quirion//Life Sci. 2002. № 71. P. 2921-2937.
Saderi, N. The NPY intergeniculate leaflet projections to the suprachiasmatic nucleus transmit metabolic conditions/F. Cazarez-Márquez, F.N. Buijs, R.C. Salgado-Delgado, M.A. Guzman-Ruiz del Carmen Basualdo M., C. Escobar, R.M. Buijs//Neuroscience. 2013. № 246. Р. 291-300.
Schwartz, M.W. Central nervous system control of food intake/S.C. Woods, D. Porte//Nature. 2000. № 404. Р. 661-671.
Tatemoto, K. Neuropeptide Y, a novel brain peptide with structural similarities to peptide YY and pancreatic peptide/M. Calquist, V. Mutt//Nature. 1982. № 268. Р. 659-660.
Turek, F.W. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists/M.U. Gillette//Sleep Med. 2004. № 5. Р. 523-532.
Wahlestedt, C. Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets/D.J. Reis//Annual Reviews of Pharmacology and Toxicology. 1993. № 32. Р.309-352.
Weber, E.T. Neuropeptide Y blocks light-induced phase advances but not delays of the circsdian activity rhythm in hamsters/M.A. Rea//Neuroscience Lett. 1997. № 231. P. 159-162.
Yannelli, P.C. Ghrelin effects on the circadian system of mice/P.C. Molyneux, M.E. Harrington, D.A. Golombek//J. Neuroscience. 2007. № 27. Р. 2890 -2895.
Yannielli, P.C. NPY applied in vitro can block phase shifts induced by light in vivo/M.E. Harrington//Neuroreport. 2000. №11. Р. 1587-1591.
Yannielli, P.C. The neuropeptide Y Y5 receptor mediates the blockade of “photic-like” NMDA-induced phase shifts/M.E. Harrington//Society for Research on Biological Rhythms. 2000. № 21. P. 5367-5373.
Zigman, J.M. Expression of ghrelin receptor mRNA in the rat and the mouse brain/J.E. Jones, C.E. Lee, C.B. Saper, J.K. Elmquist//J. Comp. Neurol. 2006. № 494. Р. 528-548.

Еще

Статья научная